Decision Reversal Sensitivity Analysis on Diabetes experiment Conditional outcome distributions mu
0Worst-case SensitivityBayesian Sensitivity Analysis
Evaluation Results
| Method | Links | |||||||
|---|---|---|---|---|---|---|---|---|
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Weight≤ 220, T = 02026.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Weight≤ 220, T = 12026.05 | 0.3 | 0.1 | 0.77 | 0.76 | 0.08 | 0.7 | 0.71 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Sex=M, T = 12026.05 | 0.84 | 0.46 | 0.91 | 0.91 | 0.4 | 0.84 | 0.84 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=HbA1c> 7.5, T = 12026.05 | 0.84 | 0.32 | 0.95 | 0.94 | 0.29 | 0.88 | 0.88 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Sex=F, T = 12026.05 | 0.85 | 0.32 | 0.95 | 0.95 | 0.3 | 0.88 | 0.88 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=HbA1c≤ 7.5, T = 12026.05 | 0.85 | 0.46 | 0.91 | 0.91 | 0.41 | 0.84 | 0.84 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Age≤ 45, T = 12026.05 | 0.88 | 0.48 | 0.9 | 0.89 | 0.42 | 0.83 | 0.83 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Age> 45, T = 12026.05 | 0.95 | 0.33 | 0.95 | 0.95 | 0.3 | 0.88 | 0.88 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=BMI≤ 28.5, T = 12026.05 | 0.95 | 0.48 | 0.92 | 0.92 | 0.51 | 0.75 | 0.76 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Sex=M, T = 02026.05 | 0.96 | 0.97 | 0.06 | 0.06 | 0.95 | 0.37 | 0.37 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Sex=F, T = 02026.05 | 0.96 | 0.97 | 0.03 | 0.03 | 0.95 | 0.41 | 0.41 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=HbA1c≤ 7.5, T = 02026.05 | 0.96 | 0.97 | 0.06 | 0.06 | 0.94 | 0.52 | 0.52 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=HbA1c> 7.5, T = 02026.05 | 0.96 | 0.97 | 0.03 | 0.03 | 0.96 | 0.12 | 0.12 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Age≤ 45, T = 02026.05 | 0.97 | 0.97 | 0.06 | 0.06 | 0.94 | 0.38 | 0.37 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Age> 45, T = 02026.05 | 0.97 | 0.97 | 0.03 | 0.03 | 0.95 | 0.66 | 0.67 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=BMI> 28.5, T = 12026.05 | 0.97 | 0.4 | 0.96 | 0.96 | 0.32 | 0.9 | 0.89 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=BMI≤ 28.5, T = 02026.05 | 0.98 | 0.97 | 0.08 | 0.08 | 0.94 | 0.51 | 0.5 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=BMI> 28.5, T = 02026.05 | 0.99 | 0.98 | 0.04 | 0.04 | 0.96 | 0.29 | 0.29 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Weight> 220, T = 02026.05 | 1 | 0.56 | 1 | 1 | 0.75 | 1 | 1 | |
| Bayesian Sensitivity AnalysisSubgroup condition (Covariate and Treatment)=Weight> 220, T = 12026.05 | 1 | 0.76 | 0.52 | 0.51 | 0.82 | 0.51 | 0.51 |